Federal Circuit denies further term extensions to shoulder surgery patentee

The US Court of Appeals for the Federal Circuit has upheld a decision by a district court that an inventor cannot further extend his shoulder surgery patent after already being granted a term adjustment period by the US Patent and Trademark Office (USPTO).

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Federal Circuit affirms district court’s Bayer ruling

2 March 2017 The US Court of Appeals for the Federal Circuit has partially affirmed a ruling by a district court in a patent dispute between Bayer and Dow Agrosciences.

Americas

Federal Circuit affirms Humira licence decision

6 February 2018 Yesterday, the US Court of Appeals for the Federal Circuit backed a lower court’s decision to dismiss a declaratory judgment lawsuit filed by AbbVie over its drug Humira.

Americas

Nicox verifies patent extension eligibility at USPTO

22 April 2021 In a boon for eye care specialist Nicox, the United States Patent and Trademark Office has confirmed that one of its three patents covering a glaucoma treatment could be extended by up to five years.

More on this story

Americas

Federal Circuit affirms district court’s Bayer ruling

2 March 2017 The US Court of Appeals for the Federal Circuit has partially affirmed a ruling by a district court in a patent dispute between Bayer and Dow Agrosciences.

Americas

Federal Circuit affirms Humira licence decision

6 February 2018 Yesterday, the US Court of Appeals for the Federal Circuit backed a lower court’s decision to dismiss a declaratory judgment lawsuit filed by AbbVie over its drug Humira.

Americas

Nicox verifies patent extension eligibility at USPTO

More on this story

Americas

Federal Circuit affirms district court’s Bayer ruling

2 March 2017 The US Court of Appeals for the Federal Circuit has partially affirmed a ruling by a district court in a patent dispute between Bayer and Dow Agrosciences.

Americas

Federal Circuit affirms Humira licence decision

6 February 2018 Yesterday, the US Court of Appeals for the Federal Circuit backed a lower court’s decision to dismiss a declaratory judgment lawsuit filed by AbbVie over its drug Humira.

Americas

Nicox verifies patent extension eligibility at USPTO